Skip to main content
. 2020 Jul 7;10:1094. doi: 10.3389/fonc.2020.01094

Figure 5.

Figure 5

In vivo effects of AMPK activator/AMPK antibody/Angustoline on KYSE450 tumor-bearing nude mice. (A) Treatment of AMPK antibody/AMPK activator/Angustoline/(AMPK antibody + Angustoline)/(AMPK activator + Angustoline) on the size of KYSE450 tumors. (B) Relative tumor volume, which was calculated by each tumor volume. *p < 0.05, comparing with the control, n = 5. (C) Tumor suppression rate, which was calculated by each tumor weight. *p < 0.05, comparing with the control, n = 5. (D) Relative tumor proliferation rate, which was calculated by relative tumor volumes of different groups. *p < 0.05, comparing with the control, n = 5.